What a Pain Society Actually Says About Injecting an Injured Disc

In 2025 the American Society of Interventional Pain Physicians published 119 pages on regenerative therapies for chronic low back pain. Thirty-five authors, thirty-three of them in the formal consensus, GRADE methodology, nineteen recommendations, and every single recommendation carried at 100% agreement.

Almost nobody in a claim file has read it. It is, nevertheless, the document that governs how this treatment is supposed to be used in the lumbar spine, and it is unusually blunt about its own limits.

The grades, target by target

The guideline does not grade “regenerative medicine.” It grades each anatomical target separately, because the evidence behind each one is different:

• Intradiscal PRP — Evidence Level III, Fair. Consensus recommendation: Moderate.
• Intradiscal bone marrow aspirate concentrate — Level III, Fair. Moderate.
• Epidural PRP — Level III, Fair. Moderate.
• Facet joint PRP and mesenchymal stem cells — Level IV, Limited. Moderate.
• Sacroiliac joint PRP — Level IV, Limited. Low.
• Functional spinal unit injections — Evidence Level Very Low. Low.

In plain language: for the disc and the epidural space, the supporting studies are mostly controlled but not top-tier, the panel reached moderate agreement that the treatment has a defined role, and the recommendation is for selected patients rather than for everyone with a sore back. For the sacroiliac joint the evidence is thinner and the recommendation is correspondingly weaker. Nobody claiming a sacroiliac indication gets to borrow the disc’s grade, and nobody treating a disc gets to borrow the knee literature.

What the guideline says besides the grades

Three things, and they are the parts a clinic selling injections would rather not print.

Diagnosis comes first. The guideline stipulates that regenerative therapy follows a thorough diagnostic evaluation. Low back pain is not a diagnosis; it is a location. The disc, the facet joints, the sacroiliac joint and the nerve root all produce pain that overlaps on the pain drawing and diverges completely on treatment. What a diagnostic block proves, and what it disproves.

It is not a monotherapy. The guideline directs that these treatments be used in conjunction with structured exercise, physical therapy and lifestyle management. An injection with no rehabilitation behind it is half a treatment plan being billed as a whole one.

It tells clinicians to talk about money before treatment. The precautions section instructs physicians to inform patients that these costs are mostly not covered by commercial insurance. The society writing the guideline and the insurer denying the claim agree completely about payment and disagree completely about evidence. Why those are two separate questions.

The limitation the guideline puts in its own text

The same document states that regenerative medicine remains in early stages of clinical validation, asks for careful optimism, and names the scarcity of high-quality studies as its central limitation.

Both things are true simultaneously, and any page that gives you only one half is selling something. A specialty society producing 119 pages, nineteen unanimous recommendations and a GRADE appraisal is evidence that this is established clinical practice with defined indications. It is not a declaration that the question is closed. Cite the levels; skip the adjectives.

Why the target matters more than the product

Patients arrive asking for PRP. That is the wrong unit of decision. The useful question is which structure is generating the signal, because that determines both the treatment and how much evidence stands behind it.

A herniated disc pressing a nerve root produces pain that is substantially chemical rather than purely mechanical, which is why an epidural intervention aimed at that inflammatory cascade can help when nothing has changed on the film. A facet-mediated pain pattern behaves differently and is confirmed differently. A sacroiliac joint is confirmed differently again. Each of those roads leads to a different grade in the table above. The middle ground between failed conservative care and major surgery.

Where a collision complicates the picture

The ASIPP guideline addresses chronic low back pain. A back injured six weeks ago is a different clinical situation, and the honest answer is that the acute phase is not where these graded recommendations were developed. Early care after an injury is about establishing the diagnosis, documenting the mechanism and the deficit, and restoring load tolerance — not about reaching for the most advanced thing available in week two.

The sequencing question also decides whether treatment survives review later. Care that follows the published order — diagnosis, conservative treatment, targeted intervention, biologic where indicated — reads as a treatment plan. Care that starts at the end reads as a product being sold, and it is valued that way by the person reviewing the file. How that review actually works.

What to take from a 119-page document

That the grades are specific, the sequence is mandatory, the payment conversation belongs before treatment rather than after it, and the society’s own caution is part of the record rather than something to be argued away. Ask which line of that table your proposed injection sits on. A physician who cannot answer has not read it either.

Frequently asked questions

What evidence level does ASIPP give intradiscal PRP?

Level III, Fair, with a moderate consensus-based clinical recommendation, in the 2025 update to its guidelines on regenerative therapies for chronic low back pain. Intradiscal bone marrow aspirate concentrate and epidural PRP carry the same grading; facet and sacroiliac indications are graded lower. Learn more: the full 2024 to 2026 guideline record.

Can PRP be injected into a herniated disc after a car accident?

It is one of the indications the 2025 ASIPP guideline addresses, at Level III, Fair with a moderate recommendation, and it applies to chronic low back pain after a thorough diagnostic evaluation rather than to the acute phase of a fresh injury. Sequencing is part of the recommendation. Learn more: what sits between conservative care and surgery.

Why does my doctor want a diagnostic block before injecting anything?

Because low back pain is a location, not a diagnosis. A block that reliably abolishes the pain and lets it return as the anesthetic wears off identifies the structure carrying the signal; a block that changes nothing has disproved an expensive assumption cheaply. Learn more: how two diagnostic blocks change a fusion conversation.

Is a sacroiliac PRP injection as well supported as a disc injection?

No. ASIPP grades sacroiliac joint PRP at Evidence Level IV, Limited, with a low consensus recommendation, compared with Level III, Fair and a moderate recommendation for intradiscal and epidural PRP. The grades are target-specific and do not transfer. Learn more: how the societies graded each indication.

Does an injection replace physical therapy?

No, and the guideline is explicit that these treatments should be used together with structured exercise, physical therapy and lifestyle management. The interventional procedure creates a window in which rehabilitation can work. Learn more: why the biological environment decides whether the window holds.

Where is Injury Experts located?

Injury Experts is at 4477 Woodson Rd, Suite 202, St. Louis, MO 63134, next to Lambert International Airport, serving the St. Louis region in Missouri and Illinois. Call (314) 887-5866 or text (314) 886-5902.

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine.

This article is for general education and is not medical advice. It does not create a physician–patient relationship. Do not start, stop, or change any medication — including opioid medication — without consulting your physician.